Post by
stokpiker on Jan 03, 2019 12:43pm
GENE GTEC
the SP for these seem to be decoupling, is the deal still happening, why has mgmt not provided an update??
the company NR in Nov included info on how the the conversion ratio would be cacluated
Under the terms of the proposed Transaction, holders of GTEC common shares will receive approximately 40% of the issued and outstanding shares of Invictus post closing.
Assuming completion of the Transaction, the issuance of Invictus shares to the current GTEC shareholders represents an approximate 25% premium to the 30-day volume weighted average trading price of the common shares of both GTEC and Invictus on the TSX Venture Exchange (“TSXV”) as of November 15, 2018.
I did a rough calc of the 30-day volume weighted avg at Nov 15 for both companies
GENE 1.40
GTEC .88 25% permium over GTEC weighted avg is 1.10
the ratio between GENE @ 1.40 and GTEC @ 1.10 is .785
so IF the deal is completed as per the NR, then GTEC shares should be worth .785 of GENE shares
if the deal was completd today with GENE trading @ .94 then GTEC would be worth .74, it's actually trading .55, so there is a .19 profit if the deal is done on the above terms, that's actually a 35% premium compared to the 25% premium when the deal was announced, why is the premium growing instead of shrinking which would normally be the case if the market expected the deal to complete
either there is a significant profit to be made on GTEC shares when the deal is completed or the deal is not going to happen or the deal terms will be changed
we need an update!!
Read more at https://www.stockhouse.com/companies/bullboard?symbol=v.gtec&postid=29182068#vVtlFWqSr3Tbdltt.99
Comment by
Tigerwoods3672 on Jan 03, 2019 12:46pm
Buy in rumours. Sell on news?